Heistø H
Transfusion. 1979 Nov-Dec;19(6):761-3. doi: 10.1046/j.1537-2995.1979.19680104105.x.
The limited value of the antiglobulin phase of the cross match when a careful antibody screening is performed was demonstrated by analyzing 73,407 compatibility tests for 23,857 patients. By the blood grouping and screening of these patients, 178 cases were detected with unexpected blood group antibodies that had not been previously observed. Unexpected antibodies were detected in an additional 13 patients by the saline phase of the cross-match. In addition, the antiglobulin phase disclosed only one patient with a very weak anti-Lea and two patients whose sera gave doubtful reactions, possibly representing antibodies, but too weak to be identified.
通过分析23857例患者的73407次相容性检测，证实了在进行仔细的抗体筛查时交叉配血抗球蛋白阶段的价值有限。通过对这些患者进行血型鉴定和筛查，检测出178例有既往未观察到的意外血型抗体。通过交叉配血盐水相又在另外13例患者中检测到意外抗体。此外，抗球蛋白阶段仅发现1例抗-Lea非常弱的患者和2例血清反应可疑的患者，后者可能代表抗体，但太弱无法鉴定。
